Perfuse Ph1/2a PER-001 Glaucoma Data Positive At AGS Meeting
03 Mar 2025 //
PR NEWSWIRE
Perfuse Announces Initiation of Enrollment to Phase 2A Clinical Trial of PER001
03 Aug 2023 //
PR NEWSWIRE
Perfuse Announces Initiation of Enrollment to Phase 1/2a Trial of PER-001
20 Jul 2023 //
PR NEWSWIRE
Perfuse Announces Clearance of IND Application for Phase 1/2a Trial of PER-001
04 Apr 2023 //
PR NEWSWIRE